PTGS2 and breast cancer: The aims of this study were to use a xenograft model of breast cancer to confirm the effect of COX-2 inhibition on tumour growth in vivo, and to subsequently determine the mechanism of action, by studying expression of markers of cell proliferation (Ki67 and p21cip1), apoptosis (TUNEL) and AKT activation.